AHR and non-small cell lung carcinoma: On the contrary, Ahr has tumor suppressor activity in NSCLC since its knockdown induces epithelial-to-mesenchymal transition and invasiveness of lung tumor cells [25] while its upregulation activates the TGFβ-Smad2 pathway, suppressing lung metastasis [26].